Chen et al. showed that the baseline titers of RF were significantly higher in patients with progressive RA-ILD, and changes in serum levels of CXCL11 and MMP-13 over 5 years were significantly associated with the progression of RA-ILD [73]. Here, CXCL11 is linked to rheumatoid arthritis.